Traber Peter G
- SEC CIK
- 0001284500
No open-market purchases or sales filed in the past year.
Current role at each company
- RNAC Cartesian Therapeutics, Inc.Chief Medical Officeras of Sep 26, 2023
- LSTA Lisata Therapeutics, Inc.Directoras of Jan 12, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Traber Peter G as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
RNAC Cartesian Therapeutics, Inc.
Chief Medical Officer5 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Sep 26, 2023 (view filing) | Sep 25 | 1 day | Traber Peter GChief Medical Officer | SSale | −705 | $1.06 | −$747.3 | −0.2%451.8K after | |
| Jan 6, 2023 (view filing) | Jan 4-5 | 2 days | Traber Peter GChief Medical Officer | SSale | −11.6K | $1.13 | −$13.2K | −2.5%446.1K after | 4 lots |
| Jan 7, 2022 (view filing) | Jan 5 | 2 days | Traber Peter GChief Medical Officer | SSale | −3.23K | $3.09 | −$9.97K | −1.3%251.4K after | |
| Dec 14, 2021 (view filing) | Dec 10 | 4 days | Traber Peter GChief Medical Officer | SSale | −4.08K | $2.99 | −$12.2K | −2.4%164.4K after | |
| Oct 15, 2021 (view filing) | Oct 13 | 2 days | Traber Peter GChief Medical Officer | SSale | −3.64K | $4.39 | −$16.0K | −2.3%154.7K after |